listing

Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

March 20, 2026 16:30 ET  | Source: Zevra Therapeutics BOSTON, March 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS:…

6 days ago

NYSE Content Update: United States Antimony Corp. Rings Bell to Mark its Listing

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 11, 2026 /PRNewswire/ -- The New York…

2 weeks ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…

3 weeks ago

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 06, 2026 17:33 ET  | Source: Tango Therapeutics Sub, Inc BOSTON, March 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics,…

3 weeks ago

KuCoin Introduces 1M USDT Futures Airdrop, Rewarding Time-in-Market on New Listings to Strengthen Listing Ecosystems

PROVIDENCIALES, Turks and Caicos Islands, March 5, 2026 /PRNewswire/ -- KuCoin, a leading global crypto platform built on trust, today…

3 weeks ago

NYSE Content Update: Sunbelt Rentals Marks NYSE Listing with Opening Bell

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 3, 2026 /PRNewswire/ -- The New York…

4 weeks ago

Orangekloud Technology Inc. Regains Compliance with Nasdaq Listing Requirements

Singapore, March 03, 2026 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (NASDAQ: ORKT) (“Orangekloud” or the “Company”), a Singapore-based technology company…

4 weeks ago

KuCoin Ranks Among Top Three Exchanges in Animoca Brands Research 2025 Listing Report

PROVIDENCIALES, Turks and Caicos Islands, Feb. 28, 2026 /PRNewswire/ -- KuCoin has been ranked among the top three cryptocurrency exchanges…

4 weeks ago

TheSportExchange Announces Intent to Pursue NASDAQ Direct Listing

Performance-linked digital asset marketplace targeting H2 2026 listing; public launch scheduled for May 1, 2026NEW YORK, Feb. 25, 2026 /PRNewswire/…

1 month ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage…

1 month ago